(877) 330-2919
Have multiple conditions? Click here
Select your condition
Tell us what's ailing you or use the guide to select multiple conditions
Choose your location
Enter your Zip Code into the guide or click on a state to find trials near you
Speak to an expert
The quickest way to get started! Get instantly connected to the right trial

Clinical Trials in Iowa (IA) | Iowa Clinical Drug Trials & Studies

You are viewing Clinical Trials In Iowa
Have multiple conditions? Click here

Showing 1-100 of 1561
There are 1561 trials in Iowa
Name City State Zip
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol West Des Moines IA 50266
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer West Des Moines IA 50266
Collecting Tumor Samples From Patients With Gynecological Tumors West Des Moines IA 50266
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy West Des Moines IA 50266
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction West Des Moines IA 50266
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer West Des Moines IA 50266
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma West Des Moines IA 50266
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer West Des Moines IA 50266
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma West Des Moines IA 50266
Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer West Des Moines IA 50266
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy West Des Moines IA 50266
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer West Des Moines IA 50266
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer West Des Moines IA 50266
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer West Des Moines IA 50266
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy West Des Moines IA 50266
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer West Des Moines IA 50266
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer West Des Moines IA 50266
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery West Des Moines IA 50266
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer West Des Moines IA 50266
Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer West Des Moines IA 50266
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer West Des Moines IA 50266
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy West Des Moines IA 50266
Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery West Des Moines IA 50266
Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial West Des Moines IA 50226
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI West Des Moines IA 50266
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy West Des Moines IA 50266
A Multicenter Clinical Study of the Sonablate®500 for the Treatment of Locally Recurrent Prostate Cancer With HIFU West Des Moines IA 50266
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study West Des Moines IA 50266
L-O-M® MCS in the Treatment of Lower Urinary Tract Symptoms West Des Moines IA 50266
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza West Des Moines IA
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Waterloo IA 50702
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Waterloo IA 50702
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Waterloo IA 50702
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy Waterloo IA 50702
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Waterloo IA 50702
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Waterloo IA 50702
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Waterloo IA 50702
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Waterloo IA 50702
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer Waterloo IA 50702
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Waterloo IA 50702
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Waterloo IA 50702
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Waterloo IA 50702
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Waterloo IA 50702
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Waterloo IA 50702
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Waterloo IA 50702
Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer Waterloo IA 50701
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer Waterloo IA 50701
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer Waterloo IA 50701
Insulin Resistance Intervention After Stroke Trial Waterloo IA 50702
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities Waterloo IA 50702
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis Waterloo IA 50702
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2 Overexpressing Metastatic Breast Cancer Patients Waterloo IA
Behavioral Trial Studying Programmed Training to Improve Advocacy Skills for Individuals With Traumatic Brain Injury Urbandale IA 50322
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Sioux City IA 51104
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Sioux City IA 51104
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Sioux City IA 51104
Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia Sioux City IA 51104
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Sioux City IA 51104
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Sioux City IA 51104
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Sioux City IA 51104
Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Sioux City IA 51104
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Sioux City IA 51104
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Sioux City IA 51104
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer Sioux City IA 51104
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Sioux City IA 51104
Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma Sioux City IA 51104
VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer Sioux City IA 51104
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Sioux City IA 51104
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy Sioux City IA 51104
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Sioux City IA 51104
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer Sioux City IA 51104
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Sioux City IA 51104
Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery Sioux City IA 51104
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Sioux City IA 51104
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma Sioux City IA 51104
Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct Sioux City IA 51104
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Sioux City IA 51104
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Sioux City IA 51104
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Sioux City IA 51104
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Sioux City IA 51104
Acute Pain Caused by Paclitaxel in Patients With Cancer Sioux City IA 51104
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Sioux City IA 51104
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer Sioux City IA 51104
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Sioux City IA 51104
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Sioux City IA 51104
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer Sioux City IA 51104
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer Sioux City IA 51104
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer Sioux City IA 51104
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Sioux City IA 51104
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies Sioux City IA 51104
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial Sioux City IA 51104
Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer Sioux City IA 51104
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer Sioux City IA 51104
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary Sioux City IA 51104
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Sioux City IA 51104
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Sioux City IA 51104
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Sioux City IA 51104
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer Sioux City IA 51104
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma Sioux City IA 51104
Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer Sioux City IA 51104
View Clinical Trial Facilities in Iowa

Showing 1-100 of 1561
browse trials by condition
helpful resources
share this page


Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
Featured Locations: Anaheim - Atlanta - Birmingham - Cleveland - DeLand - Jacksonville - Miami - Oklahoma City
About Us | Contact Us | Privacy Policy | Terms of Service | Sitemap
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Fill out the information below to find the right trial
Step 1: Contact Information
Step 2: Tell Us About Yourself



Do You Smoke
Can you stay overnight?
*Some trials require overnight observation
Step 3: Find Trials for the Following Conditions (choose all that apply)
  • Cardiology / Vascular Diseases






  • Dental / Maxillofacial Surgery

  • Dermatology / Plastic Surgery






  • Endocrinology





  • Gastroenterology








  • Hematology




  • Immunology / Infectious Diseases








  • Musculoskeletal




  • Nephrology / Urology






  • Neurology





  • Oncology












  • Ophthalmology

  • Orthopedics / Podiatry



  • Other



  • Otolaryngology


  • Pharmacology / Toxicology


  • Psychiatry / Psychology






  • Pulmonary / Respiratory Diseases








  • Reproductive






  • Rheumatology








Yes, please send me updates about the latest trials in my area

Thanks for submitting your information!
You will be contacted by one of our Clinical Trials Specialists to help guide you through the process of finding the right trial for you!
Based on your responses, we have a few additional questions (optional):
Login
Forgot password?
Enter your email and we will resend your password
Register
Change Password